135 related articles for article (PubMed ID: 18070176)
1. Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours.
Hellwinkel OJ; Kedia M; Isbarn H; Budäus L; Friedrich MG
BJU Int; 2008 Mar; 101(6):753-7. PubMed ID: 18070176
[TBL] [Abstract][Full Text] [Related]
2. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
Moelans CB; Verschuur-Maes AH; van Diest PJ
J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
[TBL] [Abstract][Full Text] [Related]
3. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
[TBL] [Abstract][Full Text] [Related]
5. PAX6 methylation and ectopic expression in human tumor cells.
Salem CE; Markl ID; Bender CM; Gonzales FA; Jones PA; Liang G
Int J Cancer; 2000 Jul; 87(2):179-85. PubMed ID: 10861471
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
8. Promoter CpG island hypermethylation during breast cancer progression.
Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
[TBL] [Abstract][Full Text] [Related]
9. Concomitant PIK3CA amplification and RASSF1A or PAX6 hypermethylation predict worse survival in gastric cancer.
Yang Q; Shao Y; Shi J; Qu Y; Wu K; Dang S; Shi B; Hou P
Clin Biochem; 2014 Jan; 47(1-2):111-6. PubMed ID: 24505629
[TBL] [Abstract][Full Text] [Related]
10. Nicotine induced CpG methylation of Pax6 binding motif in StAR promoter reduces the gene expression and cortisol production.
Wang T; Chen M; Liu L; Cheng H; Yan YE; Feng YH; Wang H
Toxicol Appl Pharmacol; 2011 Dec; 257(3):328-37. PubMed ID: 21971485
[TBL] [Abstract][Full Text] [Related]
11. Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
Kitchen MO; Bryan RT; Haworth KE; Emes RD; Luscombe C; Gommersall L; Cheng KK; Zeegers MP; James ND; Devall AJ; Fryer AA; Farrell WE
PLoS One; 2015; 10(9):e0137003. PubMed ID: 26332997
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
[TBL] [Abstract][Full Text] [Related]
13. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
Friedrich MG; Weisenberger DJ; Cheng JC; Chandrasoma S; Siegmund KD; Gonzalgo ML; Toma MI; Huland H; Yoo C; Tsai YC; Nichols PW; Bochner BH; Jones PA; Liang G
Clin Cancer Res; 2004 Nov; 10(22):7457-65. PubMed ID: 15569975
[TBL] [Abstract][Full Text] [Related]
14. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.
Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH
Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers.
Ebert MP; Mooney SH; Tonnes-Priddy L; Lograsso J; Hoffmann J; Chen J; Röcken C; Schulz HU; Malfertheiner P; Lofton-Day C
Neoplasia; 2005 Aug; 7(8):771-8. PubMed ID: 16207479
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic variations in breast cancer progression to lymph node metastasis.
Urrutia G; Laurito S; Marzese DM; Gago F; Orozco J; Tello O; Branham T; Campoy EM; Roqué M
Clin Exp Metastasis; 2015 Feb; 32(2):99-110. PubMed ID: 25628026
[TBL] [Abstract][Full Text] [Related]
18. Pax6 is a key component of regulated glucagon secretion.
Gosmain Y; Cheyssac C; Masson MH; Guérardel A; Poisson C; Philippe J
Endocrinology; 2012 Sep; 153(9):4204-15. PubMed ID: 22778220
[TBL] [Abstract][Full Text] [Related]
19. Pax6 represses androgen receptor-mediated transactivation by inhibiting recruitment of the coactivator SPBP.
Elvenes J; Thomassen EI; Johnsen SS; Kaino K; Sjøttem E; Johansen T
PLoS One; 2011; 6(9):e24659. PubMed ID: 21935435
[TBL] [Abstract][Full Text] [Related]
20. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells.
Liang G; Robertson KD; Talmadge C; Sumegi J; Jones PA
Cancer Res; 2000 Sep; 60(17):4907-12. PubMed ID: 10987305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
